State-wide Health Approach to Increase Reach and Effectiveness: Study 3 (SHARE)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01760486 |
Recruitment Status :
Completed
First Posted : January 4, 2013
Last Update Posted : January 12, 2016
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Obesity | Behavioral: Shape Up Rhode Island Behavioral: Shape Up Rhode Island + Professional Coach + Incentives Behavioral: Shape Up Rhode Island + Peer Coach + Incentives | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 300 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | Single (Outcomes Assessor) |
Primary Purpose: | Treatment |
Official Title: | Using a State-wide Initiative to Disseminate Effective Behavioral Weight Loss Strategies |
Study Start Date : | January 2013 |
Actual Primary Completion Date : | November 2015 |
Actual Study Completion Date : | November 2015 |

Arm | Intervention/treatment |
---|---|
Active Comparator: Shape Up Rhode Island
Individuals who join Shape Up Rhode Island 2013, enter our research study, and lose 5% of their initial body weight during the first two months of Shape Up will be randomized to one of the three maintenance interventions. If randomized to this treatment arm, participants will receive periodic newsletters throughout the 12 month trial.
|
Behavioral: Shape Up Rhode Island |
Experimental: Shape Up Rhode Island + Professional Coach + Incentives
Individuals who join Shape Up Rhode Island 2013, enter our research study, and lose 5% of their initial body weight during the first two months of Shape Up will be randomized to one of the three maintenance interventions. If randomized to this treatment arm, participants will receive a professional weight loss coach and will be incentivized for submitting information to their coach and meeting weight goals.
|
Behavioral: Shape Up Rhode Island + Professional Coach + Incentives |
Experimental: Shape Up Rhode Island + Peer Coach + Incentives
Individuals who join Shape Up Rhode Island 2013, enter our research study, and lose 5% of their initial body weight during the first two months of Shape Up will be randomized to one of the three maintenance interventions. If randomized to this treatment arm, participants will receive a peer coach and will be incentivized for reporting to their coach and meeting weight goals.
|
Behavioral: Shape Up Rhode Island + Peer Coach + Incentives |
- weight change from month 2 (i.e. immediately following the weight loss phase) to the 12 month follow-up assessment measured on a digital scale to the nearest 0.1 kilogram [ Time Frame: 2 to 12 months ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 70 Years (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Body Mass Index >=25kg/m2
- English speaking
Exclusion Criteria:
- Health problems that make weight loss or unsupervised exercise unsafe
- Current pregnancy or plan to become pregnant in the next 12 months
- Planned relocation
- Previous participation in Shape Up Rhode Island research studies

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01760486
United States, Rhode Island | |
The Miriam Hospital's Weight Control and Diabetes Research Center | |
Providence, Rhode Island, United States, 02903 |
Principal Investigator: | Rena R Wing, PhD | The Miriam Hospital |
Responsible Party: | The Miriam Hospital |
ClinicalTrials.gov Identifier: | NCT01760486 |
Other Study ID Numbers: |
211699-11 R18DK083248 ( U.S. NIH Grant/Contract ) |
First Posted: | January 4, 2013 Key Record Dates |
Last Update Posted: | January 12, 2016 |
Last Verified: | December 2013 |